Pericarditis after high-dose chemotherapy: more frequent than expected?
The differential diagnosis of chest pain in the setting of high-dose chemotherapy with e.g. treosulfan should include pericarditis. The pathogenesis remains unclear. Alongside infections, direct toxic or immunological drug-related mechanisms are suggested.
Right ventricular dilatation is an important modulator of outcome in patients with HF and mitral regurgitation.